Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Discovery of new phage defense systems in Vibrio cholerae

Award Number: F31AI186463
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 08/16/2024
PERIOD OF PERFORMANCE END DATE: 08/15/2025

Group Awards By:

View Award Description

Discovery of new phage defense systems in Vibrio cholerae - Abstract: Over a century ago, Felix d’ Herelle began using bacterial viruses which he termed “bacteriophages” to treat bacterial infections. Such “phage therapy” has gained new interest due to the emergence of multi-drug resistant bacterial pathogens. An advantage of phage therapy is the ability to lyse specific bacteria without disrupting the host microbiota. Although phages can infect and lyse bacteria, bacteria have evolved a myriad of molecular defense systems to protect against phage infection. This has led to the search and identification of a plethora of novel phage defense mechanisms; however, there are still a vast number of phage defense systems that have yet to be discovered and the molecular mechanism by which these systems mediate phage defense is often not well understood. My research centers on the bacterial pathogen Vibrio cholerae as it is intimately linked to phage predation both during environmental persistence and human infection. Moreover, V. cholerae has been a catalyst in the discovery of multiple novel phage defense systems. Due to its intricate relationship with phage, the central hypothesis of my thesis research is that V. cholerae encodes additional novel phage defense systems. To identify these systems, I screened a V. cholerae cosmid genomic library in Escherichia coli for segments of V. cholerae’s genome that protected E. coli from infection by T2 phage. I identified one cosmid encoding 25 kB of DNA that provided E. coli protection against T2, T4, T5, and secΦ18 infection. Transposon and deletion mutagenesis on this cosmid revealed two distinct phage defense systems. The first novel defense system involves two genes VC1767 and VC1766. Both genes are closely related to Type IV Modification Dependent systems which are known to defend against phage infection by targeting special modifications on the phage DNA. To uncover the mechanism of VC1767-66, I propose: 1) evolutionary passage to determine whether phage DNA is being modified or if escape mutants arise, 2) purification of VC1767 and VC1766 to determine their biochemical activity, and 3) quantification of phage genome replication during infection to determine when protection occurs. The second novel defense involves three genes VC1764, VC1763 and VC1762, which belong to a newly discovered but uncharacterized Zorya system. These genes are hypothesized to be an abortive infection system that kills phage infected cells to protect the surrounding population. To understand this system, I propose: 1) determine whether these three genes are sufficient to protect against phage infection, 2) evaluate proton motive force disassociation to determine if this drives defense, and 3) determine if this system exhibits abortive infection. Both systems will be further examined in V. cholerae using mutagenesis and infection with V. cholerae phage. My studies will uncover the molecular mechanisms by which these systems protect bacteria from phage infection, increasing our understanding of the evolution and ecology of V. cholerae while highlighting important mechanisms by which bacteria can resist phage therapy.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES	426 AUDITORIUM RD	EAST LANSING	MI	48824	INGHAM	USA	Allergy and Infectious Diseases Research	000	1	4/18/2025	TERMINATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $35,768 )
2024	2024	HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES	426 AUDITORIUM RD	EAST LANSING	MI	48824	INGHAM	USA	Allergy and Infectious Diseases Research	000	1	8/6/2024	NEW	$35,768
2024	2024	HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES	426 AUDITORIUM RD	EAST LANSING	MI	48824	INGHAM	USA	Allergy and Infectious Diseases Research	001	1	8/6/2024	NEW	$0
														Subtotal = $35,768

Grand Total All Awards = $35,768

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Discovery of new phage defense systems in Vibrio cholerae

Award Number: F31AI186463

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 08/16/2024

PERIOD OF PERFORMANCE END DATE: 08/15/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer